Zeskind Benjamin J. 4
4 · Immuneering Corp · Filed Feb 7, 2025
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option
2025-02-05+480,000→ 480,000 totalExercise: $1.91Exp: 2035-02-05→ Class A Common Stock (480,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029.